With Shares Down Over 60%, Is Now the Time to Buy This Healthcare Stock?

It's been a difficult year for Walgreens Boots Alliance (NASDAQ: WBA), with the stock down about 60% during the past 12 months. The question for investors is whether this is a great buying opportunity or if there is more downside ahead.Let's take a closer look at why Walgreens stock has struggled and what the company can do to turn itself around.The single biggest issue facing Walgreens is drug reimbursement prices that the company receives from pharmacy benefit managers (PBMs), which are organizations hired to keep healthcare costs down. PBMs act as middlemen between drug companies, health insurers, and pharmacies to help get discounted pricing and rebates for drug companies and set the prices insurance companies pay to pharmacies.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool